Detalles de la búsqueda
1.
Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.
Cancer Immunol Immunother
; 72(8): 2829-2840, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37188764
2.
Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma.
Invest New Drugs
; 41(1): 115-121, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36633784
3.
The Glasgow Prognostic Score Predicts Survival Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer.
Oncology
; 101(11): 695-704, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37494886
4.
The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer.
Oncology
; 101(1): 69-76, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36103811
5.
The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.
Oncology
; 101(11): 685-694, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37166346
6.
Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease.
Invest New Drugs
; 40(1): 182-189, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34415485
7.
First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study.
Invest New Drugs
; 40(2): 430-437, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34807331
8.
Medical management of older patients with lung cancer.
Jpn J Clin Oncol
; 52(10): 1082-1088, 2022 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35975674
9.
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.
Int J Clin Oncol
; 27(4): 695-706, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35182247
10.
Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibody.
Cancer Immunol Immunother
; 70(10): 2881-2892, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33751180
11.
Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913.
Invest New Drugs
; 39(1): 202-209, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32803700
12.
Phase II study of amrubicin plus erlotinib in previously treated, advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (TORG1320).
Invest New Drugs
; 39(2): 530-536, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159674
13.
Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.
BMC Cancer
; 19(1): 163, 2019 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30808322
14.
Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non-small cell lung cancer.
Invest New Drugs
; 36(1): 45-52, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28466376
15.
Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016.
BMC Cancer
; 18(1): 241, 2018 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29499653
16.
The role of prophylactic cranial irradiation for patients with small-cell lung cancer.
Jpn J Clin Oncol
; 48(1): 26-30, 2018 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29077861
17.
Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer.
Invest New Drugs
; 35(5): 642-648, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28631097
18.
A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancer.
Oncologist
; 19(11): 1194-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25260366
19.
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).
Target Oncol
; 19(3): 423-433, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38613731
20.
Small-cell lung cancer with a rare epidermal growth factor receptor gene mutation showing "wax-and-wane" transformation.
BMC Cancer
; 13: 529, 2013 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-24195468